Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts

Viranda H Jayalath, John L Sievenpiper, Russell J de Souza, Vanessa Ha, Arash Mirrahimi, Ingrid D Santaren, Sonia Blanco Mejia, Marco Di Buono, Alexandra L Jenkins, Lawrence A Leiter, Thomas M S Wolever, Joseph Beyene, Cyril W C Kendall, David J A Jenkins, Viranda H Jayalath, John L Sievenpiper, Russell J de Souza, Vanessa Ha, Arash Mirrahimi, Ingrid D Santaren, Sonia Blanco Mejia, Marco Di Buono, Alexandra L Jenkins, Lawrence A Leiter, Thomas M S Wolever, Joseph Beyene, Cyril W C Kendall, David J A Jenkins

Abstract

Objectives: Although most controlled feeding trials have failed to show an adverse effect of fructose on blood pressure, concerns continue to be raised regarding the role of fructose in hypertension. To quantify the association between fructose-containing sugar (high-fructose corn syrup, sucrose, and fructose) intake and incident hypertension, a systematic review and meta-analysis of prospective cohort studies was undertaken.

Methods: MEDLINE, EMBASE, CINAHL and the Cochrane Library (through February 5, 2014) were searched for relevant studies. Two independent reviewers reviewed and extracted relevant data. Risk estimates were aggregated comparing the lowest (reference) quintile with highest quintile of intake using inverse variance random effect models and expressed as risk ratios (RR) with 95% confidence intervals (CIs). Interstudy heterogeneity was assessed (Cochran Q statistic) and quantified (I(2) statistic). The Newcastle-Ottawa Scale assessed study quality. Clinicaltrials.gov NCT01608620.

Results: Eligibility criteria were met by 3 prospective cohorts (n = 37,375 men and 185,855 women) with 58,162 cases of hypertension observed over 2,502,357 person-years of follow-up. Median fructose intake was 5.7-6.0% total energy in the lowest quintile and 13.9-14.3% total energy in the highest quintile. Fructose intake was not associated with incident hypertension (RR = 1.02, 95% CI, 0.99-1.04), with no evidence of heterogeneity (I(2) = 0%, p = 0.59). Spline curve modeling showed a U-shaped relationship with a negative association at intakes ≤50th percentile (∼10% total energy) and a positive association at higher intakes.

Conclusions: Total fructose intake was not associated with an increased risk of hypertension in 3 large prospective cohorts of U.S. men and women.

Keywords: fructose; hypertension; meta-analysis; prospective cohort; systematic review.

Figures

Fig. 1.. Flow of the literature. Of…
Fig. 1.. Flow of the literature. Of the 3470 identified articles, 3444 were excluded based on title and abstract. The remaining 26 were reviewed in full. Three prospective cohorts were included in the meta-analysis.
Fig. 2.. Forest plot of prospective cohorts…
Fig. 2.. Forest plot of prospective cohorts investigating the association between total fructose intake and incident hypertension. The pooled effect estimate is represented as a diamond. p Values are for generic inverse variance random effects models. Interstudy heterogeneity was assessed via Cochrane's Q (χ2) at a significance level of p < 0.10 and quantified by I 2, where I 2 > 50% was considered to be evidence of substantial heterogeneity. All data are presented as relative risks with 95% confidence intervals.(Color figure available online.)
Fig. 3.. Incident hypertension across pooled quintiles…
Fig. 3.. Incident hypertension across pooled quintiles of increasing fructose intake. The x-axis represents quintiles; the y-axis represents relative risk. Each point represents a meta-analyzed relative risk of data from all cohorts across each respective quintile, compared to the reference quintile. The vertical line represents each relative risk's respective 95% confidence interval.(Color figure available online.)
Supplementary Fig. 1.. Funnel plot of risk…
Supplementary Fig. 1.. Funnel plot of risk ratios for incident hypertension comparing the lowest with the highest quintiles for fructose intake. The vertical line represents the pooled relative risk. The dashed lines represent the pseudo-95% confidence intervals of the relative risk. The circles represent risk estimates for each cohort, and the horizontal lines represent standard errors of the relative risk.

References

    1. World Health Organization . Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
    1. Tu K. Chen Z. Lipscombe LL. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ. 2008;178:1429–1435.
    1. Chobanian AV. Bakris GL. Black HR. Cushman WC. Green LA. Izzo JL. Jones DW. Materson BJ. Oparil S. Wright JT. Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
    1. Lawes CM. Vander Hoorn S. Law MR. Elliott P. MacMahon S. Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006;24:423–430.
    1. Daskalopoulou SS. Khan NA. Quinn RR. Ruzicka M. McKay DW. Hackam DG. Rabkin SW. Rabi DM. Gilbert RE. Padwal RS. Dawes M. Touyz RM. Campbell TS. Cloutier L. Grover S. Honos G. Herman RJ. Schiffrin EL. Bolli P. Wilson T. Feldman RD. Lindsay MP. Hemmelgarn BR. Hill MD. Gelfer M. Burns KD. Vallee M. Prasad GV. Lebel M. McLean D. Arnold JM. Moe GW. Howlett JG. Boulanger JM. Larochelle P. Leiter LA. Jones C. Ogilvie RI. Woo V. Kaczorowski J. Trudeau L. Bacon SL. Petrella RJ. Milot A. Stone JA. Drouin D. Lamarre-Cliche M. Godwin M. Tremblay G. Hamet P. Fodor G. Carruthers SG. Pylypchuk G. Burgess E. Lewanczuk R. Dresser GK. Penner B. Hegele RA. McFarlane PA. Sharma M. Campbell NR. Reid D. Poirier L. Tobe SW. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2012;28:270–287.
    1. Johnson RK. Appel LJ. Brands M. Howard BV. Lefevre M. Lustig RH. Sacks F. Steffen LM. Wylie-Rosett J. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120:1011–1020.
    1. Johnson RJ. Segal MS. Sautin Y. Nakagawa T. Feig DI. Kang DH. Gersch MS. Benner S. Sanchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86:899–906.
    1. Lustig RH. Schmidt LA. Brindis CD. Public health: The toxic truth about sugar. Nature. 2012;482:27–29.
    1. Johnson RJ. Sanchez-Lozada LG. Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol. 2010;21:2036–2039.
    1. Hwang IS. Ho H. Hoffman BB. Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512–516.
    1. Elliott SS. Keim NL. Stern JS. Teff K. Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76:911–922.
    1. Vasdev S. Prabhakaran VM. Whelan M. Ford CA. Longerich L. Parai S. Fructose-induced hypertension, hypertriglyceridemia and elevated cytosolic calcium in rats: prevention by deuterium oxide. Artery. 1994;21:124–147.
    1. Dai S. McNeill JH. Fructose-induced hypertension in rats is concentration- and duration-dependent. J Pharmacol Toxicol Methods. 1995;33:101–107.
    1. Catena C. Cavarape A. Novello M. Giacchetti G. Sechi LA. Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. Kidney Int. 2003;64:2163–2171.
    1. Martinez FJ. Rizza RA. Romero JC. High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension. 1994;23:456–463.
    1. Perez-Pozo SE. Schold J. Nakagawa T. Sanchez-Lozada LG. Johnson RJ. Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 2010;34:454–461.
    1. Jalal DI. Smits G. Johnson RJ. Chonchol M. Increased fructose associates with elevated blood pressure. J Am Soc Nephrol. 2010;21:1543–1549.
    1. Chen L. Caballero B. Mitchell DC. Loria C. Lin PH. Champagne CM. Elmer PJ. Ard JD. Batch BC. Anderson CA. Appel LJ. Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: a prospective study among United States adults. Circulation. 2010;121:2398–2406.
    1. Nguyen S. Choi HK. Lustig RH. Hsu CY. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr. 2009;154:807–813.
    1. Ha V. Sievenpiper JL. de Souza RJ. Chiavaroli L. Wang DD. Cozma AI. Mirrahimi A. Yu ME. Carleton AJ. Dibuono M. Jenkins AL. Leiter LA. Wolever TM. Beyene J. Kendall CW. Jenkins DJ. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension. 2012;59:787–795.
    1. Wang DD. Sievenpiper JL. de Souza RJ. Chiavaroli L. Ha V. Cozma AI. Mirrahimi A. Yu ME. Carleton AJ. Dibuono M. Jenkins AL. Leiter LA. Wolever TM. Beyene J. Kendall CW. Jenkins DJ. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr. 2012;142:916–923.
    1. Marriott BP. Cole N. Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr. 2009;139:1228S–1235S.
    1. Higgins JPT. Green S. Cochrane Collaboration . Cochrane Handbook for Systematic Reviews of Interventions.” Cochrane Book Series. Chichester, England: Wiley-Blackwell; 2008.
    1. Stroup DF. Berlin JA. Morton SC. Olkin I. Williamson GD. Rennie D. Moher D. Becker BJ. Sipe TA. Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.
    1. Moher D. Liberati A. Tetzlaff J. Altman DG. The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PloS Medicine. 2009;6 .
    1. Wells GA. Shea B. O’Connell D. Peterson J. Welch V. Losos M. Tugwell P. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000 .
    1. Stevens RD. Dowdy DW. Michaels RK. Mendez-Tellez PA. Pronovost PJ. Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33:1876–1891.
    1. Henderson A. Korner-Bitensky N. Levin M. Virtual reality in stroke rehabilitation: a systematic review of its effectiveness for upper limb motor recovery. Top Stroke Rehabil. 2007;14:52–61.
    1. Orsini N. Belloco R. Greenland S. Generalized least squares for trend estimation. Stata J. 2006;6:40–57.
    1. Greenland S. Longnecker MP. Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–1309.
    1. StataCorp LP. mkspline—Linear and restricted cubic spline construction. StataCorp LP
    1. Forman JP. Choi H. Curhan GC. Fructose and vitamin C intake do not influence risk for developing hypertension. J Am Soc Nephrol. 2009;20:863–871.
    1. Feskanich D. Rimm EB. Giovannucci EL. Colditz GA. Stampfer MJ. Litin LB. Willett WC. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc. 1993;93:790–796.
    1. Rimm EB. Giovannucci EL. Stampfer MJ. Colditz GA. Litin LB. Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1127–1136. 1114–1126; discussion.
    1. Willett WC. Sampson L. Stampfer MJ. Rosner B. Bain C. Witschi J. Hennekens CH. Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65.
    1. Cohen L. Curhan G. Forman J. Association of sweetened beverage intake with incident hypertension. J Gen Intern Med. 2012;27:1127–1134.
    1. Winkelmayer WC. Stampfer MJ. Willett WC. Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA. 2005;294:2330–2335.
    1. Brown CM. Dulloo AG. Yepuri G. Montani JP. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol. 2008;294:R730–R737.
    1. Gao X. Chen H. Choi HK. Curhan G. Schwarzschild MA. Ascherio A. Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol. 2008;167:831–838.
    1. Choi HK. Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008;336:309–312.
    1. Sun SZ. Flickinger BD. Williamson-Hughes PS. Empie MW. Lack of association between dietary fructose and hyperuricemia risk in adults. Nutr Metab (Lond) 2010;7:16. .
    1. Sievenpiper JL. de Souza RJ. Kendall CW. Jenkins DJ. Is fructose a story of mice but not men? J Am Diet Assoc. 2011;111:220–212. 219–220; author reply.
    1. Sievenpiper JL. de Souza RJ. Mirrahimi A. Yu ME. Carleton AJ. Beyene J. Chiavaroli L. Di Buono M. Jenkins AL. Leiter LA. Wolever TM. Kendall CW. Jenkins DJ. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med. 2012;156:291–304.
    1. Sievenpiper JL. Carleton AJ. Chatha S. Jiang HY. de Souza RJ. Beyene J. Kendall CW. Jenkins DJ. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care. 2009;32:1930–1937.
    1. Cozma AI. Sievenpiper JL. de Souza RJ. Chiavaroli L. Ha V. Wang DD. Mirrahimi A. Yu ME. Carleton AJ. Di Buono M. Jenkins AL. Leiter LA. Wolever TM. Beyene J. Kendall CW. Jenkins DJ. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care. 2012;35:1611–1620.
    1. Sievenpiper JL. Chiavaroli L. de Souza RJ. Mirrahimi A. Cozma AI. Ha V. Wang DD. Yu ME. Carleton AJ. Beyene J. Di Buono M. Jenkins AL. Leiter LA. Wolever TM. Kendall CW. Jenkins DJ. “Catalytic” doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr. 2012;108:418–423.
    1. Willett W. Nutritional epidemiology. New York: Oxford University Press; 1998.
    1. Sievenpiper JL. de Souza RJ. Are sugar-sweetened beverages the whole story? Am J Clin Nutr. 2013;98:261–263.
    1. Madero M. Arriaga JC. Jalal D. Rivard C. McFann K. Perez-Mendez O. Vazquez A. Ruiz A. Lanaspa MA. Jimenez CR. Johnson RJ. Lozada LG. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial. Metabolism. 2011;60:1551–1559.
    1. Winkleby MA. Jatulis DE. Frank E. Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82:816–820.
    1. Bray GA. Nielsen SJ. Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537–543.

Source: PubMed

3
Abonneren